Pharmhouse Corp Cash Flow Conversion Efficiency
Pharmhouse Corp cash flow conversion efficiency. Based on the latest financial reports, Pharmhouse Corp (PHSE) has a cash flow conversion efficiency ratio of 0.008x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($362.87K) by net assets ($46.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Pharmhouse Corp (1996–2025)
Cash flow conversion efficiency of Pharmhouse Corp from 1996 to 2025. This chart illustrates how Pharmhouse Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Pharmhouse Corp share price for real-time trading data and today's change.
Pharmhouse Corp Cash Flow Conversion Ratio Explained
Pharmhouse Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Pharmhouse Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharmhouse Corp ranked by their cash flow conversion efficiency. Also see PHSE company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zaigle Co. Ltd
KQ:234920
|
-0.099x |
|
RSUPPORT Co. Ltd
KQ:131370
|
0.000x |
|
Aura Energy Ltd
AU:AEE
|
-0.078x |
|
Osmond Resources Ltd
AU:OSM
|
-0.021x |
|
Westhaven Ventures Inc
V:WHN
|
0.024x |
|
Chang Type Industrial Co Ltd
TW:1541
|
0.021x |
|
W5 Solutions AB
ST:W5
|
0.074x |
|
Direct Line Insurance Group plc
LSE:DLG
|
-0.069x |
Annual Cash Flow Conversion Efficiency for Pharmhouse Corp (1996–2025)
The table below shows the annual cash flow conversion efficiency of Pharmhouse Corp from 1996 to 2025. Review PHSE free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $52.30 Million | $-2.49 Million | -0.048x | -107.78% |
| 2024-12-31 | $-1.00 Million | $-614.75K | 0.612x | +108.47% |
| 2023-12-31 | $-236.54K | $1.71 Million | -7.229x | -65709.72% |
| 2021-12-31 | $6.47 Million | $-71.12K | -0.011x | +96.42% |
| 2020-12-31 | $6.36 Million | $-1.95 Million | -0.307x | -827.23% |
| 2019-12-31 | $-19.68K | $652.00 | -0.033x | +99.02% |
| 1998-12-31 | $570.54K | $-1.93 Million | -3.377x | -553.85% |
| 1997-12-31 | $3.54 Million | $-1.83 Million | -0.517x | -35.81% |
| 1996-12-31 | $6.41 Million | $-2.44 Million | -0.380x | -- |
About Pharmhouse Corp
Pride Holdings Group operates as a LGBTQ-focused entertainment, hospitality, and lifestyle company in the United States. It engages in the bar, pub, tavern, restaurant, hotels, nightclubs, and live adult entertainment industry businesses. The company was formerly known as Parliament House Enterprises, Inc. and changed its name to Pride Holdings Group in July 2025. Pride Holdings Group is based in… Read more